Christopher I. Li, MD, PhD, MPH

Research Associate Professor, Epidemiology

Contact Information
Fred Hutchinson Cancer Research Center
1100 Fairview Ave N., M4-C308
P.O. 19024
Seattle, WA 98109-1024
Tel: 206-667-7444
Fax: 206-667-5948
http://www.fhcrc.org/
cili@fhcrc.org

Affiliations
Fred Hutchinson Cancer Research Center ( Associate Member )

Research Interests

My research interests lie principally in the field of breast cancer and understanding factors related to its etiology and outcomes using a multidisciplinary approach. I am actively investigating the relationships between various hormonal exposures and risks of different types of breast cancer based on their morphology and expression of different tumor markers. I am also interested in breast cancer outcomes and am currently leading studies that investigate risk factors for second primary breast cancer among breast cancer survivors. Another part of my work focuses on identifying markers that could be used for the early detection of different cancers using various proteomic platforms. Finally, I have an interest in examining disparities in cancer stage, treatment, and survival by race/ethnicity.

Teaching Interests
Dr. Li currently co-teaches Epidemiology 524: Cancer Epidemiology during Winter Quarter.

Education
MD, Medicine, University of California (San Francisco) 2000
PhD, Epidemiology, University of Washington 2003
MPH, Epidemiology, University of Washington 2000

Projects
For information on projects - go to Dr. Li's FHCRC webpage

Selected Publications
Li CI, Malone KE, Saltzman BS, Daling JR. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001. Cancer 2006;106:2104-2112.

Li CI, Daling JR, Malone KE, Bernstein L, Marchbanks PA, Liff JM, Strom BL, Simon MS, Press MF, McDonald JA, Ursin G, Burkman RT, Deapen D, Spirtas R. Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer. Cancer Epidemiol Biomarker Prev 2006;15:946-954.

Li CI, Malone KE, Porter PL, Weiss NS, Tang MC, Cushing-Haugen KL, Daling JR. The relationship between long-term use of hormone replacement therapy and risk of breast cancer among women 65-79 years of age. JAMA 2003;289:3254-3263.

Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 2003;163:49-56.

Li CI, Malone KE, Weiss NS, Daling JR. Use of tamoxifen for primary breast cancer in relation to risk of ontralateral breast cancer. J Natl Cancer Inst 2001;93:1008-1013.

Links
Community of Science Expertise